Merck KGaA (OTCMKTS:MKGAF) Reaches New 1-Year High at $194.33

Merck KGaA (OTCMKTS:MKGAFGet Free Report)’s share price reached a new 52-week high on Thursday . The company traded as high as $194.33 and last traded at $194.33, with a volume of 55 shares traded. The stock had previously closed at $187.81.

Merck KGaA Price Performance

The stock has a 50-day moving average price of $174.42 and a two-hundred day moving average price of $172.06. The company has a current ratio of 1.29, a quick ratio of 0.82 and a debt-to-equity ratio of 0.28. The stock has a market cap of $25.12 billion, a price-to-earnings ratio of 27.58 and a beta of 0.96.

About Merck KGaA

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

Read More

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.